SciClone Pharmaceuticals (Holdings) Limited 賽生藥業控股有限公司

Pay for financial year ended 2021-12-31

Source: Annual report

Note: while most data are extracted from annual reports, some data in these tables may have been taken from supplemental filings made in response to complaints to SEHK by our volunteer editors. Please report any errors.

Name Last
position
Fees Salary &
benefits
Bonus Retire Share-
based
Total

CNY '000

Directors

1 Chen, Ping (1958) INED 569 569
2 Gu, Alex Yushao INED 569 569
3 Hayes, Wendy (1970) INED 569 569
4 Li, Quan (SFC:BHH844) 李泉 NED
5 Li, Zhenfu (1963-07) 李振福 NED, Ch
6 Lin, Shirley Yi Hsien NED
7 Liu, Guoen 劉國恩 INED 569 569
8 Shi, Cen (1975) 石岑 NED
9 Vasella, Daniel Luzius NED 569 569
10 Wang, Haixia (1973) 王海霞 NED
11 Wang, Xiaozhuo 王曉卓 NED
12 Zhao, Hong (1963) 趙宏 Pres, CEO 7,407 18,433 25,840
Total 2,845 7,407 0 0 18,433 28,685

Main board pay history

Click on the year-end to see the pay details.

CNY'000

Year-end Fees Salary &
benefits
Bonus Retire Share-
based
Total
2023-12-31 3,290 13,946 0 107 18,199 35,542 Report
2022-12-31 3,290 7,938 0 0 9,092 20,320 Report
2021-12-31 2,845 7,407 0 0 18,433 28,685 Report
2020-12-31 0 6,794 0 0 21,963 28,757 Report
Total 9,425 36,085 0 107 67,687 113,304

Want to see more years here? volunteer to be a Webb-database editor and add the data from annual reports!


Copyright & disclaimer, Privacy policy

Back to top